148 related articles for article (PubMed ID: 11821722)
1. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.
Liberopoulos E; Christides D; Elisaf M
J Hypertens; 2002 Feb; 20(2):347. PubMed ID: 11821722
[No Abstract] [Full Text] [Related]
2. Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.
Würzner G; Gerster JC; Chiolero A; Maillard M; Fallab-Stubi CL; Brunner HR; Burnier M
J Hypertens; 2001 Oct; 19(10):1855-60. PubMed ID: 11593107
[TBL] [Abstract][Full Text] [Related]
3. Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population.
Dang A; Zhang Y; Liu G; Chen G; Song W; Wang B
J Hum Hypertens; 2006 Jan; 20(1):45-50. PubMed ID: 16281062
[TBL] [Abstract][Full Text] [Related]
4. Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients.
Chida R; Hisauchi I; Toyoda S; Kikuchi M; Komatsu T; Hori Y; Nakahara S; Sakai Y; Inoue T; Taguchi I
Hypertens Res; 2015 Nov; 38(11):765-9. PubMed ID: 26178150
[TBL] [Abstract][Full Text] [Related]
5. An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan.
Bunt T
Clin Ther; 1999 Mar; 21(3):611-2. PubMed ID: 10321426
[No Abstract] [Full Text] [Related]
6. [GOUT AND HYPERTENSION].
Belovol AN; Knyazkova II; Miroshnykova IA
Lik Sprava; 2015; (1-2):32-8. PubMed ID: 26118024
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.
Kassler-Taub K; Littlejohn T; Elliott W; Ruddy T; Adler E
Am J Hypertens; 1998 Apr; 11(4 Pt 1):445-53. PubMed ID: 9607383
[TBL] [Abstract][Full Text] [Related]
8. Irbesartan treatment in hypertension.
Brown MJ
Hosp Med; 1998 Oct; 59(10):808-11. PubMed ID: 9850301
[TBL] [Abstract][Full Text] [Related]
9. Problems with interpreting the data in Kassler-Taub et al's article comparing irbesartan and losartan.
Bunt T
Am J Hypertens; 1999 Jan; 12(1 Pt 1):79-81. PubMed ID: 10075390
[No Abstract] [Full Text] [Related]
10. Ambulatory blood pressure comparison of the anti-hypertensive efficacy of fixed combinations of irbesartan/hydrochlorothiazide and losartan/hydrochlorothiazide in patients with mild-to-moderate hypertension.
Neutel JM; Smith D
J Int Med Res; 2005; 33(6):620-31. PubMed ID: 16372579
[TBL] [Abstract][Full Text] [Related]
11. Effect of losartan versus candesartan on uric acid, renal function, and fibrinogen in patients with hypertension and hyperuricemia associated with diuretics.
Rayner BL; Trinder YA; Baines D; Isaacs S; Opie LH
Am J Hypertens; 2006 Feb; 19(2):208-13. PubMed ID: 16448895
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin receptor blockers -- finally the evidence is coming in: IDNT and RENAAL.
Coats AJ
Int J Cardiol; 2001 Jul; 79(2-3):99-102. PubMed ID: 11461726
[No Abstract] [Full Text] [Related]
13. Comparison of effects of losartan, irbesartan, and candesartan on flow-mediated brachial artery dilation and on inflammatory and thrombolytic markers in patients with systemic hypertension.
Koh KK; Han SH; Chung WJ; Ahn JY; Jin DK; Kim HS; Park GS; Kang WC; Ahn TH; Shin EK
Am J Cardiol; 2004 Jun; 93(11):1432-5, A10. PubMed ID: 15165934
[TBL] [Abstract][Full Text] [Related]
14. The effects of a low-salt diet on the efficacy of different antihypertensive drug regimens.
Wang J; Qiu B; Du JL; Deng SB; Liu YJ; She Q
J Clin Pharmacol; 2015 Dec; 55(12):1362-8. PubMed ID: 26053853
[TBL] [Abstract][Full Text] [Related]
15. Differences in pharmacology and their translation into differences in clinical efficacy--a comparison of the renin angiotensin blocking agents irbesartan and losartan.
Bramlage P; Schindler C
Expert Opin Pharmacother; 2010 Mar; 11(4):521-35. PubMed ID: 20030566
[TBL] [Abstract][Full Text] [Related]
16. [The effects of angiotensin II receptor blockers in hypertensive patients complicating hyperuricaemia].
Dang AM; Liu GZ; Zhang YH; Chen GL;
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):882-5. PubMed ID: 17217711
[TBL] [Abstract][Full Text] [Related]
17. Hypertension, diuretics, and uric acid.
Reyes AJ; Leary WP
Am J Hypertens; 2006 Oct; 19(10):1093-4. PubMed ID: 17027836
[No Abstract] [Full Text] [Related]
18. Irbesartan slows the development of diabetic nephropathy by up to 70% in hypertensive diabetic patients.
Cardiovasc J S Afr; 2001; 12(4):242-3. PubMed ID: 11766619
[No Abstract] [Full Text] [Related]
19. Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy.
Croom KF; Curran MP; Goa KL; Perry CM
Drugs; 2004; 64(9):999-1028. PubMed ID: 15101793
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor blockers and nephropathy trials.
Bloomgarden ZT
Diabetes Care; 2001 Oct; 24(10):1834-8. PubMed ID: 11574450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
